PB125

Nrf2 activator

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Other treatment

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Link	Tested on	Impact factor	Notes	Publication date
Nrf2 Activator PB125® as a Potential Therapeutic Agent Against COVID-19 Preprint	primary human pulmonary artery endothelial cells			May/17/2020

Link	Publication date
Nrf2 Activator PB125 as a Potential Therapeutic Agent against COVID-19	Nov/01/2021